Both in Biotechnology
Anavex Life Sciences vs Neumora Therapeutics
Over the past year AVXL returned −83.1% and NMRA returned −79.7%; their daily moves had a correlation of 0.11.
AVXL −83.1% NMRA −79.7%Growth of $1, one year, split-adjusted
| Metric | AVXL | NMRA |
|---|---|---|
| Price | $1.26 | $0.5660 |
| Market cap | $116.8M | $106.3M |
| Today | +5.00% | −0.86% |
| 1 month | −21.3% | +20.2% |
| 6 months | −62.3% | −75.7% |
| Year to date | −64.6% | −68.4% |
| 1 year | −83.7% | −81.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $118.3M | $63.9M |
| Dividend yield | — | — |
| Volatility (60d) | 74.4% | 125.6% |
| Short % of float | 14.0% | 6.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).